Literatura académica sobre el tema "Vaginal immunization"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Vaginal immunization".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Vaginal immunization"
Parr, Earl L. y Margaret B. Parr. "Immunoglobulin G, Plasma Cells, and Lymphocytes in the Murine Vagina after Vaginal or Parenteral Immunization with Attenuated Herpes Simplex Virus Type 2". Journal of Virology 72, n.º 6 (1 de junio de 1998): 5137–45. http://dx.doi.org/10.1128/jvi.72.6.5137-5145.1998.
Texto completoJohansson, Eva-Liz, Carola Rask, Margareta Fredriksson, Kristina Eriksson, Cecil Czerkinsky y Jan Holmgren. "Antibodies and Antibody-Secreting Cells in the Female Genital Tract after Vaginal or Intranasal Immunization with Cholera Toxin B Subunit or Conjugates". Infection and Immunity 66, n.º 2 (1 de febrero de 1998): 514–20. http://dx.doi.org/10.1128/iai.66.2.514-520.1998.
Texto completoWira, C. R. y C. P. Sandoe. "Specific IgA and IgG antibodies in the secretions of the female reproductive tract: effects of immunization and estradiol on expression of this response in vivo." Journal of Immunology 138, n.º 12 (15 de junio de 1987): 4159–64. http://dx.doi.org/10.4049/jimmunol.138.12.4159.
Texto completoEriksson, Kristina, Marianne Quiding-Järbrink, Jacek Osek, Åke Möller, Stellan Björk, Jan Holmgren y Cecil Czerkinsky. "Specific-Antibody-Secreting Cells in the Rectums and Genital Tracts of Nonhuman Primates following Vaccination". Infection and Immunity 66, n.º 12 (1 de diciembre de 1998): 5889–96. http://dx.doi.org/10.1128/iai.66.12.5889-5896.1998.
Texto completoLivingston, Julie B., Shan Lu, Harriet Robinson y Deborah J. Anderson. "Immunization of the Female Genital Tract with a DNA-Based Vaccine". Infection and Immunity 66, n.º 1 (1 de enero de 1998): 322–29. http://dx.doi.org/10.1128/iai.66.1.322-329.1998.
Texto completoWang, Yichuan, Yongjun Sui, Jason Steel, John Morris y Jay Berzofsky. "Vaginal type-II mucosa acts as an inductive site during the generation of primary CD8+ T cell mucosal immune responses (P3186)". Journal of Immunology 190, n.º 1_Supplement (1 de mayo de 2013): 124.4. http://dx.doi.org/10.4049/jimmunol.190.supp.124.4.
Texto completoMedaglini, Donata, Marco R. Oggioni y Gianni Pozzi. "Vaginal Immunization with Recombinant Gram-Positive Bacteria". American Journal of Reproductive Immunology 39, n.º 3 (marzo de 1998): 199–208. http://dx.doi.org/10.1111/j.1600-0897.1998.tb00354.x.
Texto completoUehling, David T., Walter J. Hopkins, Jean Jensen y Edward Balish. "Vaginal Immunization Against Induced Cystitis in Monkeys". Journal of Urology 137, n.º 2 (febrero de 1987): 327–29. http://dx.doi.org/10.1016/s0022-5347(17)44015-8.
Texto completoHogge, Christopher James, Sabrina Helmold Hait, Gospel Enyindah-Asonye, Zuena Mushtaq, Tanya Hoang y Marjorie Robert-Guroff. "Replicating Ad-SIV recombinant vaccines elicit mucosal humoral immunity in rhesus macaques at both rectal and vaginal sites with potential protective efficacy". Journal of Immunology 202, n.º 1_Supplement (1 de mayo de 2019): 72.2. http://dx.doi.org/10.4049/jimmunol.202.supp.72.2.
Texto completoHymel, Terri J., Joseph Sherman, Sandra K. Pope y Kelly J. Kelleher. "Inadequate Immunizations". Clinical Pediatrics 32, n.º 3 (marzo de 1993): 156–60. http://dx.doi.org/10.1177/000992289303200306.
Texto completoTesis sobre el tema "Vaginal immunization"
Philosof, Bar. "A bacterium from the human microbiota as a vaccine vector. Efficient priming of the murine immune system by vaginal delivery of recombinant Streptococcus gordonii". Doctoral thesis, Università di Siena, 2022. http://hdl.handle.net/11365/1216735.
Texto completoLogerot, Sandrine. "Utilisation de l’interleukine-7 en immunothérapie chez des patients VIH-mauvais répondeurs immunologiques et comme adjuvant de vaccination muqueuse chez le macaque rhésus". Thesis, Sorbonne Paris Cité, 2015. http://www.theses.fr/2015USPCB111.
Texto completoHighly Active Antiretroviral Therapy (HAART) has led to significant reduction of HIV-associated mortality by maintaining an undetectable viral load and inducing progressive CD4-T cell restoration. However, some patients, defined as poor immunological responders (PIR), fail to restore their CD4 counts to 500cells/µL during treatment, a threshold considered as the protective against AIDS related or non AIDS related malignancies, opportunistic infections and cardiovascular events. Interleukin-7 (IL-7), an essential cytokine for thymopoïesis and T cell homeostasis has been used in clinical trials aimed at restoring and maintaining CD4 counts in PIR patients. The first part of my thesis project aimed at assessing the impact of IL-7 therapy on circulating HIV reservoir. In the clinical study we worked on (INSPIRE 3, Cytheris), cycles of IL-7 injections led to a significant increase of the number of circulating CD4 and CD8 T-cells, with a predominance of naïve and central memory T cell expansion. We have shown that one cycle of IL-7 injections induced a significant increase in the number of circulating infected cells 28 days and 3 months post-injections. However, despite a significant increase in the frequency of infected CD4 T-cells 28 days post-injections, we observed a significant decrease of HIV-DNA load in CD4 T-cells in the majority of patients 3 months after the therapy initiation. These data suggest a partial elimination of HIV infected cells. After the second cycle of IL-7 injections, we did not observed any change in the number or frequency of circulating infected cells, suggesting a differential impact of the two IL-7 injection cycles on the dynamics of circulating HIV-reservoir. Finally, considering that some patients developed anti-IL-7 neutralizing antibodies (Nab) after the second cycle of IL-7 injections, we looked for predictive factors of this immunogenicity and analyzed its physiological consequences in vivo. The only parameter that distinguished Nab and non-Nab patients was the extent of CD4 T-cell reconstitution during the first cycle of therapy. This suggests that a better response to IL-7 also facilitates the development of auto-antibodies to the cytokine. However, these antibodies were only transiently detectable after the second cycle of therapy. Moreover, the appearance of Nab was associated with a significant but transient decrease of thymocyte proliferation, suggesting a functional impact of these antibodies on the endogenous IL-7 function. Systemic injection of IL-7 induces circulating T cells homing from the blood into lymphoid and non-lymphoid tissues. In the second part of my thesis project, I evaluated whether this cytokine could be used as an adjuvant when sprayed on the vaginal mucosa. Ten micrograms of IL-7 directly sprayed in the vaginal tract of rhesus monkeys induced, 48h after administration, the production of a large pattern of chemokines in the vaginal chorion and epithelium. This chemokine expression was accompanied by massive homing of CD4 and CD8-T cells, macrophages, dendritic cells and NK cells in the vaginal mucosa, suggesting an increased immunological vigilance. Finally, the adjuvant potential of this cytokine was confirmed by analyzing local humoral immune response after vaginal administration of antigens 48h following IL-7 spray. In cervicovaginal washes (CVL) of treated animals, we observed a faster, stronger and longer-lasting specific IgA and IgG response than in control animals, highlighting the capacity of IL-7 to prepare the vaginal mucosa response to local antigen stimulation
Ambrose, Zandrea. "Immune control of SHIV in macaques upon mucosal infection of immunization /". Thesis, Connect to this title online; UW restricted, 2001. http://hdl.handle.net/1773/9290.
Texto completoCapítulos de libros sobre el tema "Vaginal immunization"
Thapar, M. A., E. L. Parr y M. B. Parr. "Effects of intravaginal and pelvic immunization on specific antibody in mouse vaginal fluid". En Advances in Mucosal Immunology, 606–7. Dordrecht: Springer Netherlands, 1990. http://dx.doi.org/10.1007/978-94-009-1848-1_185.
Texto completoUgwumadu, Austin. "General and specific infections in pregnancy including immunization". En Oxford Textbook of Obstetrics and Gynaecology, editado por Sabaratnam Arulkumaran, William Ledger, Lynette Denny y Stergios Doumouchtsis, 213–32. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198766360.003.0017.
Texto completoInformes sobre el tema "Vaginal immunization"
Chattopadhyay, Ishita, John Townsend y Saumya RamaRao. Offering progesterone contraceptive vaginal rings for postpartum women through integrated family planning and immunization services. Population Council, 2015. http://dx.doi.org/10.31899/rh9.1023.
Texto completo